KKR Lands Preferred Bid for Avisena Stake, Buys 6% of BookMyShow
KKR sits 30% above its 52-week low of $82.67.
Summary
KKR is the preferred bidder for a 20-25% stake in Malaysia's Avisena Healthcare, valuing the company at about $370M, with a deal possible by early September. Separately, KKR agreed on Aug 18 to buy roughly 6% of India's BookMyShow for $40-50M, valuing the ticketing platform at $667-833M. These add to KKR's active deal pipeline, which already includes the DCC Energy and EDF Power Solutions acquisitions. The firm's Q2 showed record AUM of $796B and strong fee-related earnings, so these smaller investments fit its expansion strategy. Watch for the Avisena signing in early September and regulatory approvals for BookMyShow.
At the time of this announcement, KKR was trading at $107.19 on NYSE in the Finance sector, with a market capitalization of approximately $96.2B. The 52-week trading range was $82.67 to $152.10. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.